{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:11:26Z","timestamp":1793067086163,"version":"4.5.0"},"reference-count":39,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2025,10,31]]},"DOI":"10.5582\/bst.2025.01220","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T22:09:02Z","timestamp":1758838142000},"page":"566-580","source":"Crossref","is-referenced-by-count":1,"title":["Neurotropin alleviates Alzheimer's disease pathology by inhibiting FUS-mediated Calhm2 transcription, blocking the Calhm2\/EFhd2 interaction, to improve mitochondrial dysfunction-associated microglia polarization"],"prefix":"10.5582","volume":"19","author":[{"given":"Yuanlu","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Operative Medicine, Medical Center of Anesthesiology and Pain, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusheng","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Operative Medicine, Medical Center of Anesthesiology and Pain, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoe","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Operative Medicine, Medical Center of Anesthesiology and Pain, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinqi","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Operative Medicine, Medical Center of Anesthesiology and Pain, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziye","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Operative Medicine, Medical Center of Anesthesiology and Pain, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Operative Medicine, Medical Center of Anesthesiology and Pain, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Vejandla B, Savani S, Appalaneni R, Veeravalli RS, Gude SS. Alzheimer&apos;s Disease: The Past, Present, and Future of a Globally Progressive Disease. Cureus. 2024; 16:e51705.","DOI":"10.7759\/cureus.51705"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Li X, Feng X, Sun X, Hou N, Han F, Liu Y. Global, regional, and national burden of Alzheimer&apos;s disease and other dementias, 1990-2019. Front Aging Neurosci. 2022; 14:937486.","DOI":"10.3389\/fnagi.2022.937486"},{"key":"3","unstructured":"3. GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022; 7:e105-e125."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Knopman DS, Amieva H, Petersen RC, Ch\u00e9telat G, Holtzman DM, Hyman BT, Nixon RA, Jones DT. Alzheimer disease. Nat Rev Dis Primers. 2021; 7:33.","DOI":"10.1038\/s41572-021-00269-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, Vergallo A. The Amyloid-\u03b2 Pathway in Alzheimer&apos;s Disease. Mol Psychiatry. 2021; 26:5481-5503.","DOI":"10.1038\/s41380-021-01249-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Zhang H, Wei W, Zhao M, Ma L, Jiang X, Pei H, Cao Y, Li H. Interaction between A\u03b2 and Tau in the Pathogenesis of Alzheimer&apos;s Disease. Int J Biol Sci. 2021; 17:2181-2192.","DOI":"10.7150\/ijbs.57078"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Toda K, Muneshige H, Ikuta Y. Antinociceptive effects of neurotropin in a rat model of painful peripheral mononeuropathy. Life Sci. 1998; 62:913-921.","DOI":"10.1016\/S0024-3205(98)00009-5"},{"key":"8","unstructured":"8. Fang W, Liao W, Zheng Y, Huang X, Weng X, Fan S, Chen X, Zhang X, Chen J, Xiao S, Thea A, Luan P, Liu J. Neurotropin reduces memory impairment and neuroinflammation <i>via<\/i> BDNF\/NF-\u03baB in a transgenic mouse model of Alzheimer&apos;s disease. Am J Transl Res. 2019; 11:1541-1554."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Miao J, Ma H, Yang Y, Liao Y, Lin C, Zheng J, Yu M, Lan J. Microglia in Alzheimer&apos;s disease: pathogenesis, mechanisms, and therapeutic potentials. Front Aging Neurosci. 2023; 15:1201982.","DOI":"10.3389\/fnagi.2023.1201982"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Guo S, Wang H, Yin Y. Microglia Polarization From M1 to M2 in Neurodegenerative Diseases. Front Aging Neurosci. 2022; 14:815347.","DOI":"10.3389\/fnagi.2022.815347"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wang C, Zong S, Cui X, Wang X, Wu S, Wang L, Liu Y, Lu Z. The effects of microglia-associated neuroinflammation on Alzheimer&apos;s disease. Front Immunol. 2023; 14:1117172.","DOI":"10.3389\/fimmu.2023.1117172"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer&apos;s disease. J Cell Biol. 2018; 217:459-472.","DOI":"10.1083\/jcb.201709069"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Agrawal I, Jha S. Mitochondrial Dysfunction and Alzheimer&apos;s Disease: Role of Microglia. Front Aging Neurosci. 2020; 12:252.","DOI":"10.3389\/fnagi.2020.00252"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Cheng J, Dong Y, Ma J, Pan R, Liao Y, Kong X, Li X, Li S, Chen P, Wang L, Yu Y, Yuan Z. Microglial Calhm2 regulates neuroinflammation and contributes to Alzheimer&apos;s disease pathology. Sci Adv. 2021; 7:eabe3600.","DOI":"10.1126\/sciadv.abe3600"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Rubio-Moscardo F, Set\u00f3-Salvia N, Pera M, <i>et al<\/i>. Rare variants in calcium homeostasis modulator 1 (CALHM1) found in early onset Alzheimer&apos;s disease patients alter calcium homeostasis. PLoS One. 2013; 8:e74203.","DOI":"10.1371\/journal.pone.0074203"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mun MJ, Kim JH, Choi JY, Jang WC. Calcium homeostasis modulator 1 gene P86L polymorphism and the risk for alzheimer&apos;s disease: A meta-analysis. Neurosci Lett. 2016; 619:8-14.","DOI":"10.1016\/j.neulet.2016.02.049"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ma Z, Taruno A, Ohmoto M, <i>et al<\/i>. CALHM3 Is Essential for Rapid Ion Channel-Mediated Purinergic Neurotransmission of GPCR-Mediated Tastes. Neuron. 2018; 98:547-561.e10.","DOI":"10.1016\/j.neuron.2018.03.043"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Deng J, Wang P, Chen X, Cheng H, Liu J, Fushimi K, Zhu L, Wu JY. FUS interacts with ATP synthase beta subunit and induces mitochondrial unfolded protein response in cellular and animal models. Proc Natl Acad Sci U S A. 2018; 115:E9678-E9686.","DOI":"10.1073\/pnas.1806655115"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sahadevan S, Hembach KM, Tantardini E, P\u00e9rez-Berlanga M, Hruska-Plochan M, Megat S, Weber J, Schwarz P, Dupuis L, Robinson MD, De Rossi P, Polymenidou M. Synaptic FUS accumulation triggers early misregulation of synaptic RNAs in a mouse model of ALS. Nat Commun. 2021; 12:3027.","DOI":"10.1038\/s41467-021-23188-8"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Jiang T, Tan L, Zhu XC, Zhang QQ, Cao L, Tan MS, Gu LZ, Wang HF, Ding ZZ, Zhang YD, Yu JT. Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer&apos;s disease. Neuropsychopharmacology. 2014; 39:2949-2962.","DOI":"10.1038\/npp.2014.164"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Bhatia S, Rawal R, Sharma P, Singh T, Singh M, Singh V. Mitochondrial Dysfunction in Alzheimer&apos;s Disease: Opportunities for Drug Development. Curr Neuropharmacol. 2022; 20:675-692.","DOI":"10.2174\/1570159X19666210517114016"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ishikawa T, Yasuda S, Minoda S, Ibuki T, Fukuhara K, Iwanaga Y, Ariyoshi T, Sasaki H. Neurotropin<sup>\u00ae<\/sup> ameliorates chronic pain <i>via<\/i> induction of brain-derived neurotrophic factor. Cell Mol Neurobiol. 2015; 35:231-241.","DOI":"10.1007\/s10571-014-0118-x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Mutoh T, Yamamoto S, Moriya T. Correction: Mutoh <i>et al<\/i>. Post-Event Application of Neurotropin Protects against Ischemic Insult toward Better Outcomes in a Murine Model of Subarachnoid Hemorrhage. Biomedicines 2021, 9, 664. Biomedicines. 2024; 12:2033.","DOI":"10.3390\/biomedicines12092033"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Wu YG, Song LJ, Yin LJ, Yin JJ, Wang Q, Yu JZ, Xiao BG, Ma CG. The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer&apos;s disease. Neural Regen Res. 2023; 18:947-954.","DOI":"10.4103\/1673-5374.355747"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Misrani A, Tabassum S, Yang L. Mitochondrial Dysfunction and Oxidative Stress in Alzheimer&apos;s Disease. Front Aging Neurosci. 2021; 13:617588.","DOI":"10.3389\/fnagi.2021.617588"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Potenza MA, Sgarra L, Desantis V, Nacci C, Montagnani M. Diabetes and Alzheimer&apos;s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path? Antioxidants (Basel). 2021; 10:1257.","DOI":"10.3390\/antiox10081257"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. An J, Zhou Y, Zhang M, Xie Y, Ke S, Liu L, Pan X, Chen Z. Exenatide alleviates mitochondrial dysfunction and cognitive impairment in the 5\u00d7FAD mouse model of Alzheimer&apos;s disease. Behav Brain Res. 2019; 370:111932.","DOI":"10.1016\/j.bbr.2019.111932"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Li J, Wang L, Zeng Q, He J, Tang Q, Wang K, He G. MKP-1 regulates the inflammatory activation of microglia against Alzheimer&apos;s disease. CNS Neurosci Ther. 2024; 30:e14409.","DOI":"10.1111\/cns.14409"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Goodison WV, Frisardi V, Kehoe PG. Calcium channel blockers and Alzheimer&apos;s disease: potential relevance in treatment strategies of metabolic syndrome. J Alzheimers Dis. 2012; 30 Suppl 2:S269-282.","DOI":"10.3233\/JAD-2012-111664"},{"key":"30","unstructured":"30. Tan Y, Deng Y, Qing H. Calcium channel blockers and Alzheimer&apos;s disease. Neural Regen Res. 2012; 7:137-140."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Huang BR, Chang PC, Yeh WL, Lee CH, Tsai CF, Lin C, Lin HY, Liu YS, Wu CY, Ko PY, Huang SS, Hsu HC, Lu DY. Anti-neuroinflammatory effects of the calcium channel blocker nicardipine on microglial cells: implications for neuroprotection. PLoS One. 2014; 9:e91167.","DOI":"10.1371\/journal.pone.0091167"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Liao Y, Wang Y, Tao QQ, Yang C, Wang J, Cheng J, Ma J, Wu ZY, Pan RY, Yuan Z. CALHM2 V136G polymorphism reduces astrocytic ATP release and is associated with depressive symptoms and Alzheimer&apos;s disease risk. Alzheimers Dement. 2023; 19:4407-4420.","DOI":"10.1002\/alz.13366"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Deng H, Gao K, Jankovic J. The role of FUS gene variants in neurodegenerative diseases. Nat Rev Neurol. 2014; 10:337-348.","DOI":"10.1038\/nrneurol.2014.78"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Woulfe J, Gray DA, Mackenzie IR. FUS-immunoreactive intranuclear inclusions in neurodegenerative disease. Brain Pathol. 2010; 20:589-597.","DOI":"10.1111\/j.1750-3639.2009.00337.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Doi H, Koyano S, Suzuki Y, Nukina N, Kuroiwa Y. The RNA-binding protein FUS\/TLS is a common aggregate-interacting protein in polyglutamine diseases. Neurosci Res. 2010; 66:131-133.","DOI":"10.1016\/j.neures.2009.10.004"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Ishigaki S, Masuda A, Fujioka Y, Iguchi Y, Katsuno M, Shibata A, Urano F, Sobue G, Ohno K. Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions. Sci Rep. 2012; 2:529.","DOI":"10.1038\/srep00529"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Dhar SK, Zhang J, Gal J, Xu Y, Miao L, Lynn BC, Zhu H, Kasarskis EJ, St Clair DK. FUsed in sarcoma is a novel regulator of manganese superoxide dismutase gene transcription. Antioxid Redox Signal. 2014; 20:1550-1566.","DOI":"10.1089\/ars.2012.4984"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Bo X, Xie F, Zhang J, Gu R, Li X, Li S, Yuan Z, Cheng J. Deletion of Calhm2 alleviates MPTP-induced Parkinson&apos;s disease pathology by inhibiting EFHD2-STAT3 signaling in microglia. Theranostics. 2023; 13:1809-1822.","DOI":"10.7150\/thno.83082"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Tu Y, Zhang L, Tong L, Wang Y, Zhang S, Wang R, Li L, Wang Z. EFhd2\/swiprosin-1 regulates LPS-induced macrophage recruitment <i>via<\/i> enhancing actin polymerization and cell migration. Int Immunopharmacol. 2018; 55:263-271.","DOI":"10.1016\/j.intimp.2017.12.030"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/19\/5\/19_2025.01220\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T04:03:17Z","timestamp":1763179397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/19\/5\/19_2025.01220\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2025.01220","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"article-number":"2025.01220"}}